UBS Group’s Pulmonx LUNG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $715K | Buy |
275,895
+192,833
| +232% | +$499K | ﹤0.01% | 4589 |
|
|
2025
Q1 | $559K | Sell |
83,062
-118,776
| -59% | -$799K | ﹤0.01% | 4601 |
|
|
2024
Q4 | $1.37M | Buy |
201,838
+180,665
| +853% | +$1.23M | ﹤0.01% | 4007 |
|
|
2024
Q3 | $176K | Sell |
21,173
-1,462
| -6% | -$12.1K | ﹤0.01% | 4793 |
|
|
2024
Q2 | $144K | Sell |
22,635
-24,705
| -52% | -$157K | ﹤0.01% | 4779 |
|
|
2024
Q1 | $439K | Buy |
47,340
+13,665
| +41% | +$127K | ﹤0.01% | 4193 |
|
|
2023
Q4 | $429K | Buy |
33,675
+9,624
| +40% | +$123K | ﹤0.01% | 4079 |
|
|
2023
Q3 | $248K | Sell |
24,051
-2,226
| -8% | -$23K | ﹤0.01% | 4116 |
|
|
2023
Q2 | $344K | Sell |
26,277
-1,498
| -5% | -$19.6K | ﹤0.01% | 4101 |
|
|
2023
Q1 | $311K | Buy |
27,775
+14,986
| +117% | +$168K | ﹤0.01% | 4036 |
|
|
2022
Q4 | $108K | Sell |
12,789
-391
| -3% | -$3.3K | ﹤0.01% | 4915 |
|
|
2022
Q3 | $220K | Buy |
13,180
+4,685
| +55% | +$78.2K | ﹤0.01% | 3990 |
|
|
2022
Q2 | $125K | Sell |
8,495
-4,538
| -35% | -$66.8K | ﹤0.01% | 4268 |
|
|
2022
Q1 | $324K | Sell |
13,033
-2,142
| -14% | -$53.3K | ﹤0.01% | 4048 |
|
|
2021
Q4 | $486K | Buy |
15,175
+11,895
| +363% | +$381K | ﹤0.01% | 4008 |
|
|
2021
Q3 | $118K | Buy |
3,280
+3,000
| +1,071% | +$108K | ﹤0.01% | 4646 |
|
|
2021
Q2 | $12K | Sell |
280
-4,254
| -94% | -$182K | ﹤0.01% | 6788 |
|
|
2021
Q1 | $207K | Buy |
4,534
+2,455
| +118% | +$112K | ﹤0.01% | 4491 |
|
|
2020
Q4 | $143K | Buy |
+2,079
| New | +$143K | ﹤0.01% | 4487 |
|